These data indicated that blocking IL-8/STAT3 signaling of TAMs can evidently hinder the communication between the tumor and the host stromal cells, suggesting it as a novel therapeutic target for cancer stem cells that mediate the evolution of ovarian cancer and other malignant diseases. The gene discussed is STAT3; the disease is neoplasm.